Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.19−0.02 (-10.00%)
Close on Nov 18, 2026Market cap $852.76KP/E –Yield –
Oragenics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Oragenics's free cash flow for the twelve months ending Dec 31, 2022 was -$15.36M. For fiscal 2022 it was -$15.36M. The highest annual figure on record is -$5.22M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$15.36M | – |
| FY2021 | Dec 31, 2021 | -$13.51M | – |
| FY2019 | Dec 31, 2019 | -$13.04M | – |
| FY2018 | Dec 31, 2018 | -$9.20M | – |
| FY2016 | Dec 31, 2016 | -$7.10M | – |
| FY2015 | Dec 31, 2015 | -$5.29M | – |
| FY2014 | Dec 31, 2014 | -$5.67M | – |
| FY2013 | Dec 31, 2013 | -$6.78M | – |
| FY2012 | Dec 31, 2012 | -$5.22M | – |
| FY2010 | Dec 31, 2010 | -$6.54M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$2.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.81M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.72M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.04M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.96M | – |
See a number that looks wrong?